View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- 10x Genomics, Inc.Operating co.
- President and Fellows of Harvard CollegeUniversity / research
Representatives- Tobias Wuttke-Bardehle Pagenberg
Respondents- Bruker Spatial Biology, Inc.Operating co.
- Luxendo GmbHOperating co.
- Bruker Nederland B.V.Operating co.
- Bruker CorporationOperating co.
Representatives- Oliver Jan Jüngst-Bird & Bird LLP
- Division
- Munich LD
- Technology
- InstrumentsAnalysis of biological materials
- ChemistryBiotechnology
- Language
- —
- First decided
- Apr 11, 2025
- EPO Opposition
- NanoString Technologies, Inc.Admissible2023-07-18
- König Szynka Tilmann von RenesseAdmissible2024-03-07
- Vizgen, Inc.Withdrawn2024-03-07
- Bruker Spatial Biology, Inc.Withdrawn2023-07-18
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge András Kupecz | Locked |
| Judge Tobias Pichlmaier | Locked |
At the UPC: 10x Genomics, Inc. (40 cases)·NanoString Group (21 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 2 other proceedings
13 other defendants litigating the same or a related patent
UPC CFI 3233/2026·UPC CFI 1594/2026·UPC CoA 681/2025·UPC CoA 808/2024·UPC CoA 654/2024 and 8 more
Decisions
- 2025-04-11
Summary: The Munich Local Division ruled on continuation of written proceedings in the 10x Genomics v. Bruker infringement action, holding that four auxiliary requests is a reasonable number under Rule 30.1(c) RoP and authorising continuation of the written procedure following the EPO Opposition Division's decision maintaining the patent in limited form.
Show the legal issues (5)
- Auxiliary requests
- R.30.1(c) RoP
- Continuation of written proceedings
- Amendment of patent after EPO opposition
- Reasonable number of requests
Documents
- 17D69364E9E37210C194A4711312D6FE_en.pdf2025-04-11EN